Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.
暂无分享,去创建一个
R Brookmeyer | R. Siliciano | J. Margolick | R. Brookmeyer | R. Chaisson | D. Richman | D. Ho | T. Pierson | M. Markowitz | J. Gallant | T. Quinn | D. Finzi | K. Chadwick | L. Carruth | M. Heřmánková | C. Buck | D D Richman | D D Ho | M Markowitz | R E Chaisson | T Pierson | R F Siliciano | K Chadwick | J Margolick | T C Quinn | D Finzi | M Hermankova | L M Carruth | C Buck | J Gallant
[1] E A Emini,et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. , 1997, The New England journal of medicine.
[2] P. Lipsky,et al. Phenotypic and functional characterization of human T cell clones. , 1988, Journal of immunology.
[3] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[4] L. McQuay,et al. Dilution assay statistics , 1994, Journal of clinical microbiology.
[5] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[6] J. Coffin,et al. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.
[7] N. Shen,et al. Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arrays , 1996, Nature Medicine.
[8] M. Zupancic,et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. , 1997, Science.
[9] J. Mellors,et al. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor , 1996, Journal of virology.
[10] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[11] J. van Lunzen,et al. Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph‐node CD4+ T cells , 1997, AIDS.
[12] D. Ho,et al. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir , 1996, Nature Medicine.
[13] H. Nitschko,et al. Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959. , 1995, AIDS research and human retroviruses.
[14] R. Gallo,et al. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[15] Robert F. Siliciano,et al. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency , 1995, Nature Medicine.
[16] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[17] P. Sharp,et al. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation , 1992, Journal of virology.
[18] D. Ho,et al. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.
[19] Ashley T. Haase,et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS , 1993, Nature.